RSS

personalised medicine

Dr. Moritz Kneipp, product manager liquid flow sensors, Sensirion, explains the challenges that are faced when developing personalised medicine. Read more

News

Contract development and manufacturing organisation (CDMO) The Almac Group has announced it is expanding its Edinburgh Technopole facility to help scale-up its personalised cancer vaccine activities. Read more

News

Immuno-oncology (I-O) and personalised medicine are set to be at the forefront of the pharmaceutical industry in 2019, data shows. Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

NHS England has announced a landmark deal, giving children and young people access to Novartis’ Kymriah (a chimeric antigen receptor T-cell, CAR-T, therapy) — a personalised therapy for the treatment of cancer. Read more

News

Deloitte and Vineti have entered into a teaming agreement for the collaborative development of end-to-end solutions to support personalised medicine. Read more

News

The July/August issue of EPM magazine is available for download with all the regulars and features on legal — IP, sterilisation, ACHEMA review, excipients, personalised medicine plus a drug delivery supplement. Read more

Latest Issue

Here, Trevor Marshall, director of global engineering at Zenith Technologies, goes into detail about how integrating and automating cell therapy production with MES will help grow the personalised medicine sector and ultimately benefit patients Read more

Opinion

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

According to data and analytics company, GlobalData, personalised medicine is becoming an increasing possibility for patients as a result of newly developed algorithms and the use of big data. Read more

Analysis

According to new research from the US, a side-effect of a common prostate cancer drug can, in some men with advanced disease who have a specific genetic variant, actually fuel cancer cells. Read more

News

Despite the ongoing trend in digital tech across the board, pharma is still lagging behind in unlocking the potential of these useful tools… Read more

Opinion

In this article, Maria Andrielou, marketing & communication, and Thanos Andreou, scientific affairs, at VIO Chemicals, give their views on how to get the best out of process R&D. Read more

, Opinion

Diagnostics company, Owlstone Medical, has signed a service agreement with global biopharmaceutical company, AstraZeneca, to explore how breath can be used to identify novel biomarkers for personalised medicine applications. Read more

News

Contract CRO, Aptus Clinical, is to be one of 12 partners to receive government funding that will be used to ensure more patients benefit from a new generation of disease-fighting medicines for cancer and non-cancer illnesses Read more

News

At this year’s successful pharma packaging and drug delivery exhibition and conference, Pharmapack Europe, experts highlighted forthcoming major industry trends as being personalised medicines, intelligent packaging and US FDA deadlines Read more

Analysis

Today, the FDA will convene the Oncologic Drugs Advisory Committee to review Novartis’ personalised cancer therapy, CTL019. The first discussion point of the meeting will focus on manufacturing and product quality control Read more

News

Dragon Master Foundation has announced plans to provide financial and collaborative support to a clinical trial that will make patient data available live in the cloud while the trial is underway. Read more

News

Global healthcare company Novo Nordisk, alongside global pharmaceutical company Pfizer, are investing $9 million into the Swedish-based digital health company AMRA. Read more

News

Personalised medicine is being heralded as the future. Harnessing big data in medicine yields valuable insights and advances knowledge. Read more

News